Target intelligence / Profile preview

RNA, U6 small nuclear 1223, pseudogene (RNU6-1223P)

Target: RNU6-1223P
Molecular classification: Small nuclear RNA pseudogene, Non-coding RNA pseudogene, Pseudogene

Overview

**RNA, U6 small nuclear 1223, pseudogene (RNU6-1223P)** is a processed pseudogene originating from the U6 small nuclear RNA gene family. U6 snRNA is essential for the catalytic activity of the spliceosome, which excises introns from pre-mRNA in eukaryotes[3][1][5]. However, RNU6-1223P itself does not produce a functional RNA molecule, does not participate in splicing, and is not known to encode a protein or have a direct biological function[5][7]. Like other U6 snRNA pseudogenes, it is a genomic relic derived from retrotransposition events, likely via LINE-1-mediated mechanisms, and it is not considered a drug target or functional regulatory RNA at this time[5]. There is no current evidence linking this pseudogene specifically to disease or therapeutic applications.

Other names: RNU6-1223PRNA, U6 Small Nuclear 1223, Pseudogene

Biological functions

None (pseudogenes generally lack biological function; canonical U6 snRNA is involved in pre-mRNA splicing, but this does not apply to the pseudogene)

Disease associations

Other (no evidence to support involvement in specific diseases; pseudogenes can sometimes play regulatory roles, but this is not described for RNU6-1223P)

Beyond the preview

Go deeper on RNA, U6 small nuclear 1223, pseudogene (RNU6-1223P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1223, pseudogene (RNU6-1223P).

Explore the full profile